Kelly Goldsmith
- Department of Pediatrics
Professor
-
Aflac Cancer and Blood Disorders Center
Pediatrics
1760 Haygood Drive
Academic Appointment
- Associate Professor of Pediatrics, Emory University
Education
Degrees
- MD from University of Alabama School of Medicine
- BS from Duke University
Research
Focus
- My research focuses on the molecular mechanisms of chemoresistance in neuroblastoma (NB), a highly lethal pediatric solid tumor, and on the use of experimental therapeutics to restore therapy sensitivity through the re-engagement of programmed cell death.
Publications
-
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia.
Pediatr Blood Cancer Volume: 72 Page(s): e31714
07/01/2025 Authors: Karol SE; Khaw SL; Zwaan CM; Baruchel A; Bittencourt H; Cooper TM; Flotho C; Fraser C; Forlenza CJ; Goldsmith KC -
Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.
J Clin Oncol Page(s): JCO2402612
06/23/2025 Authors: Cash T; Marachelian A; DuBois SG; Chi Y-Y; Baregamyan A; Groshen SG; Jonus HC; Shamirian A; Crowley M; Goodarzian F -
Protocol for 3D bioprinting of a 3D in vitro model of neuroblastoma.
STAR Protoc Volume: 6 Page(s): 103725
06/20/2025 Authors: Amoli MS; Rezapourdamanab S; Jin L; Cadena MA; Kaw K; Sridhar V; Meselhe M; Krikor S; Mahmoudi M; Ning L -
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
Pediatr Blood Cancer Page(s): e31831
06/12/2025 Authors: DuBois SG; Moreno L; Anderson J; Asgharzadeh S; Bagatell R; Beck-Popovic M; Belle J; Berlanga P; Bird NJ; Chesler L -
Trends in analgesia-sedation of pediatric patients receiving I-131 MIBG in the pediatric intensive care unit: A report from the Pediatric Health Information System database.
Pediatr Blood Cancer Volume: 71 Page(s): e31205
10/01/2024 Authors: Dhuse J; Cash T; Elges MS; Alazraki A; Beer R; Jergel A; Goldsmith KC; Hall M; Kamat PP -
Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma.
J Natl Compr Canc Netw Volume: 22
08/01/2024 Authors: Irwin MS; Goldsmith KC -
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.
Commun Biol Volume: 7 Page(s): 426
04/08/2024 Authors: Mittal K; Cooper GW; Lee BP; Su Y; Skinner KT; Shim J; Jonus HC; Kim WJ; Doshi M; Almanza D -
Children's Oncology Group's 2023 blueprint for research: Neuroblastoma.
Pediatr Blood Cancer Volume: 70 Suppl 6 Page(s): e30572
09/01/2023 Authors: Bagatell R; DuBois SG; Naranjo A; Belle J; Goldsmith KC; Park JR; Irwin MS; COG Neuroblastoma Committee -
A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
Volume: 70 Page(s): e30405
08/01/2023 Authors: Cash T; Jonus HC; Tsvetkova M; Beumer JH; Sadanand A; Lee JY; Henry CJ; Aguilera D; Harvey RD; Goldsmith KC -
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma.
Cell Rep Med Volume: 4 Page(s): 101091
06/20/2023 Authors: Lee JY; Jonus HC; Sadanand A; Branella GM; Maximov V; Suttapitugsakul S; Schniederjan MJ; Shim J; Ho A; Parwani KK